Adamant Biomedical Investments’s HOSPIRA INC HSP Stock Holding History

Adamant Biomedical Investments’s Portfolio HSP Stock Details HSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	$5.51M	Buy	+90,000	New	+$5.08M	1.32%	25

Other funds holding HSP

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

Tran Capital Management San Rafael, California $869M AUM 52.91% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Adamant Biomedical Investments's HSP Position: Q4 2014 in Review

Adamant Biomedical Investments opened a new position in HOSPIRA INC (HSP) in Q4 2014: 90,000 shares worth $5.51M. The stake represents 1.32% of the portfolio and ranks #25 among its holdings.

452 funds tracked by Wall St. Rank hold HSP as of Q4 2014.

Adamant Biomedical Investments held 90,000 shares of HOSPIRA INC worth $5.51M as of Q4 2014.
HOSPIRA INC was a new Adamant Biomedical Investments position in Q4 2014.
HOSPIRA INC made up 1.32% of Adamant Biomedical Investments's portfolio in Q4 2014, its #25 holding.
452 funds tracked by Wall St. Rank held HOSPIRA INC as of Q4 2014.

Based on Adamant Biomedical Investments's 13F filing for Q4 2014, filed 13 Feb 2015.